Backed by Science and Doctors

Where It's Made Matters

Recoverase is manufactured by our trusted partner in a FDA, HACCP, and cGMP certified, adhering to the strict manufacturing protocols of ISO 22000, pharmaceutical-grade facility, ensuring maximum safety, quality, and effectiveness.
Every capsule is produced with care, under strict health protocols.

• Strengthens post-vaccine immune recovery

• Made with science-backed ingredients

• Trusted by medical professionals

• No prescriptions needed

• manufactured by our trusted partner in a FDA, HACCP, and cGMP certified

• Safe, easy, and convenient to take

Why Choose Recoverase?

If You’ve Been Vaccinated… This Was Made Specifically for YOU

Recoverase offers supplements to support immunity post-COVID-19 vaccination, addressing IGG4 antibody concerns for a healthier future.

6-Ingredient Scientific Based Formulation

That mitigate, lessen the side effect of covid-19 vaccines and support overall heath and recovery.

Boost Your Immunity

Its support your immune system post-COVID-19 vaccination for better health.

Immune Support Bundle

Three variants designed to enhance your immune response effectively and safely.

Recovery Essentials

Essential supplements to help restore your body's natural defenses after vaccination.

Health Restoration Pack

A comprehensive solution for boosting immunity and overall health after vaccination.

Explore our products

How Recoverase Works

Clinical Studies Reference

Hulscher, N., Procter, B. C., Wynn, C., & McCullough, P. A. (2023). Clinical approach to post-acute sequelae after COVID-19 infection and vaccination. Cureus, 15(11).
Matende, N. (2024). Elimination/Neutralization of COVID-19 Vaccine-Produced Spike Protein: Scoping Review. Mathews Journal of Nutrition & Dietetics, 7(2), 1-23.Okeahialam, B. N. (2024). COVID-19 treatment: Nattokinase, a fibrinolytic serine protease is the low-hanging fruit. Santosh University Journal of Health Sciences, 10(2), 279-282.Tanikawa, T., Kiba, Y., Yu, J., Hsu, K., Chen, S., Ishii, A., Yokogawa, T., Suzuki, R., Inoue, Y., & Kitamura, M. (2022). Degradative Effect of Nattokinase on Spike Protein of SARS-CoV-2. Molecules (Basel, Switzerland), 27(17), 5405. https://doi.org/10.3390/molecules27175405Andersen, L. E. In the Name of Science.Kyriakopoulos, A. M., & Seneff, S. (2023). Proteolytic targets for SARS-CoV-2 spike protein degradation: Hope for systemic detoxification. Journal of American Physicians and Surgeons, 28(3), 86-93.McCullough, P. A., Wynn, C., & Procter, B. C. (2023). Clinical rationale for SARS-CoV-2 base spike protein detoxification in post COVID-19 and vaccine injury syndromes. J Am Physicians Surg, 28, 90-93.Hulscher, N., Procter, B. C., Wynn, C., & McCullough, P. A. (2023). Clinical Approach to Post-acute Sequelae After COVID-19 Infection and Vaccination. Cureus, 15(11), e49204. https://doi.org/10.7759/cureus.49204https://drjessesantiano.com/bromelain-for-long-covid-and-post-vaccine-syndrome/Brien, S., Lewith, G., Walker, A., Hicks, S. M., & Middleton, D. (2004). Bromelain as a Treatment for Osteoarthritis: A Review of Clinical Studies. Evidence-Based Complementary and Alternative Medicine, 1(3), 251. https://doi.org/10.1093/ecam/neh035Sagar, S., Rathinavel, A. K., Lutz, W. E., Struble, L. R., Khurana, S., Schnaubelt, A. T., Mishra, N. K., Guda, C., Broadhurst, M. J., M Reid, S. P., Bayles, K. W., O Borgstahl, G. E., & Radhakrishnan, P. (2020). Bromelain Inhibits SARS-CoV-2 Infection in VeroE6 Cells. BioRxiv, 2020.09.16.297366. https://doi.org/10.1101/2020.09.16.297366Pavan, R., Jain, S., & Kumar, A. (2012). Properties and Therapeutic Application of Bromelain: A Review. Biotechnology Research International, 2012, 976203. https://doi.org/10.1155/2012/976203Felton G. E. (1980). Fibrinolytic and antithrombotic action of bromelain may eliminate thrombosis in heart patients. Medical hypotheses, 6(11), 1123–1133. https://doi.org/10.1016/0306-9877(80)90134-6Jagadeesan, P., Jagadeesan, R., & Ramachandran, R. (2021). Bromelain: A potential therapeutic solution for COVID-19. International Journal of Scientific & Engineering Research, 12(10), 487. https://www.ijser.orgJagadeesan, P., Jagadeesan, R., & Ramachandran, R. (2021). Bromelain: A potential therapeutic solution for COVID-19. International Journal of Scientific & Engineering Research, 12(10), 487. https://www.ijser.orgHikisz, P. (2021). Beneficial Properties of Bromelain. Nutrients, 13(12), 4313. https://doi.org/10.3390/nu13124313Kumar, V., Mangla, B., Javed, S., Ahsan, W., Kumar, P., Garg, V., & Dureja, H. (2023). Bromelain: A review of its mechanisms, pharmacological effects and potential applications. Food & function.Sagar, S., Rathinavel, A. K., Lutz, W. E., Struble, L. R., Khurana, S., Schnaubelt, A. T., Mishra, N. K., Guda, C., Palermo, N. Y., Broadhurst, M. J., Hoffmann, T., Bayles, K. W., M. Reid, S. P., O. Borgstahl, G. E., & Radhakrishnan, P. (2021). Bromelain inhibits SARS-CoV-2 infection via targeting ACE-2, TMPRSS2, and spike protein. Clinical and Translational Medicine, 11(2), e281. https://doi.org/10.1002/ctm2.281Akhter, J., Pillai, K., Badar, S., Mekkawy, A., Valle, S. J., & Morris, D. L. (2020). In vitro study of BromAc on SARS-CoV-2 spike and envelope protein shows synergy and disintegration at modest concentrations. bioRxiv. https://doi.org/10.1101/2020.09.07.286906Sayıner, S., Velioğlu-Öğünç, A., & Şehirli, A. Ö. (2021). Bromelain: A potential therapeutic application in SARS-CoV-2 infected patients. Annals of Antivirals and Antiretrovirals, 5(1), 015-018.
McCullough, P. A., Wynn, C., & Procter, B. C. (2023). Clinical rationale for SARS-CoV-2 base spike protein detoxification in post COVID-19 and vaccine injury syndromes. J Am Physicians Surg, 28, 90-93.
Hulscher, N., Procter, B. C., Wynn, C., & McCullough, P. A. (2023). Clinical Approach to Post-acute Sequelae After COVID-19 Infection and Vaccination. Cureus, 15(11), e49204. https://doi.org/10.7759/cureus.49204in, C., Lee, J., Park, C., Choi, Y. H., & Kim, G. (2007). Curcumin attenuates the release of pro-inflammatory cytokines in lipopolysaccharide-stimulated BV2 microglia. Acta Pharmacologica Sinica, 28(10), 1645–1651.Yu, Y., Shen, Q., Lai, Y., Park, S. Y., Ou, X., Lin, D., Jin, M., & Zhang, W. (2018). Anti-inflammatory Effects of Curcumin in Microglial Cells. Frontiers in Pharmacology, 9, 345045. https://doi.org/10.3389/fphar.2018.00386Ak, T., & Gülçin, I. (2008). Antioxidant and radical scavenging properties of curcumin. Chemico-biological interactions, 174(1), 27–37. https://doi.org/10.1016/j.cbi.2008.05.003Barzegar, A., & Moosavi-Movahedi, A. A. (2011). Intracellular ROS protection efficiency and free radical-scavenging activity of curcumin. PloS one, 6(10), e26012. https://doi.org/10.1371/journal.pone.0026012aurindo, L. F., De Carvalho, G. M., Figueira, M. E., Direito, R., Buglio, D. S., & Barbalho, S. M. (2022). Curcumin-Based Nanomedicines in the Treatment of Inflammatory and Immunomodulated Diseases: An Evidence-Based Comprehensive Review. Pharmaceutics, 15(1), 229. https://doi.org/10.3390/pharmaceutics15010229Widjaja, Sry Suryani; Rusdiana, Rusdiana; Amelia, Rina1. Curcumin: Boosting the immunity of COVID-19-vaccinated populations. Journal of Advanced Pharmaceutical Technology & Research 13(3):p 187-190, Jul–Sep 2022. | DOI: 10.4103/japtr.japtr_54_22Fessler, S. N., Chang, Y., Liu, L., & Johnston, C. S. (2022). Curcumin Confers Anti-Inflammatory Effects in Adults Who Recovered from COVID-19 and Were Subsequently Vaccinated: A Randomized Controlled Trial. Nutrients, 15(7), 1548. https://doi.org/10.3390/nu15071548Allegra, A., Mirabile, G., Ettari, R., Pioggia, G., & Gangemi, S. (2021). The Impact of Curcumin on Immune Response: An Immunomodulatory Strategy to Treat Sepsis. International Journal of Molecular Sciences, 23(23), 14710. https://doi.org/10.3390/ijms232314710Vahedian-Azimi, A., Abbasifard, M., Rahimi-Bashar, F., Guest, P. C., Majeed, M., Mohammadi, A., Banach, M., Jamialahmadi, T., & Sahebkar, A. (2022). Effectiveness of Curcumin on Outcomes of Hospitalized COVID-19 Patients: A Systematic Review of Clinical Trials. Nutrients, 14(2), 256. https://doi.org/10.3390/nu14020256Zahedipour, F., Hosseini, S. A., Sathyapalan, T., Majeed, M., Jamialahmadi, T., Al-Rasadi, K., Banach, M., & Sahebkar, A. (2020). Potential effects of curcumin in the treatment of COVID-19 infection. Phytotherapy research : PTR, 34(11), 2911–2920. https://doi.org/10.1002/ptr.6738McCullough, P. A., Wynn, C., & Procter, B. C. (2023). Clinical rationale for SARS-CoV-2 base spike protein detoxification in post COVID-19 and vaccine injury syndromes. J Am Physicians Surg, 28, 90-93.Hulscher, N., Procter, B. C., Wynn, C., & McCullough, P. A. (2023). Clinical Approach to Post-acute Sequelae After COVID-19 Infection and Vaccination. Cureus, 15(11), e49204. https://doi.org/10.7759/cureus.49204

Legal Disclaimer: Recoverase is a dietary supplement and is not intended to diagnose, treat, cure, or prevent any disease. The statements on this website have not been evaluated by the Food and Drug Administration (FDA). If you are pregnant, nursing, taking medication, or have any medical condition, consult your healthcare provider before using this or any other supplement.

Copyright © 2025 Recoverase. All Rights Reserved.

Recoverase is a product of Nanuci Philippines . All content on this website is provided for informational purposes only and reflects the author's personal opinions and findings. The content and product are provided “AS IS” and “AS AVAILABLE,” with no guarantees or warranties of any kind.

You are encouraged to conduct your own research and consult a qualified medical professional before making any health-related decisions. The information on this site is not intended to replace professional medical advice, diagnosis, or treatment from a licensed practitioner.

Testimonials and case studies featured on this site are provided by actual users of Recoverase and related products. These accounts represent individual experiences, which may not reflect typical results, and are not intended to guarantee that any user will achieve the same or similar outcomes.